WebHikal Ltd manufactures chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. Its products are distributed to pharmaceuticals, biotech, agrochemicals, and specialty chemical industries. Its segments include crop protection and pharmaceuticals. The majority of the revenue is derived from the ... WebMay 5, 2024 · Hikal is a reliable long-term partner to companies in the pharmaceuticals, crop protection, and specialty chemicals industry. The company is in the business of supplying research services, active ingredients and intermediates, manufactured using stringent global quality standards, for its global customers.
Hikal (BSE:524735) - Share price, News & Analysis - Simply Wall St
WebFeb 3, 2024 · HIKAL LTD. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRY : PHARMACEUTICALS Hikal Ltd. NSE: HIKAL BSE: 524735 Expensive Performer Check Buy or Sell 282.15 12.65 (4.69%) 38.12% Fall from 52W High 711.3K NSE+BSE Volume NSE Mar 29, 2024 03:31 PM Watchlist Portfolio My Notes 9 S 4 W 2 O 0 T 19.3 Broker average … WebPatheon pharma services provide industry-leading CDMO services as well as clinical trial solutions. With more than 60 locations around the globe, our end-to-end drug … impeachment reconstruction era
Who We Are Hikal
WebHikal Ltd Share Price Today - Hikal Ltd Share Price LIVE on NSE/BSE Hikal Ltd HIKAL 287.20 1.97 % (+5.55) Place Order Go Pro! to unlock score, rank and other metrics How to use scorecard? Learn more Overview Forecasts Financials Peers Holdings News Events 1.0 k WebCheck Hikal share price, financial data and complete stock analysis.Get Hikal stock rating based on quarterly result, profit and loss account, balance sheet, shareholding pattern and annual report. ... 4:23PM Hikal signs 10-year multi product deal with leading global pharmaceutical innovator company 5 May 2024, 9:45AM Hikal informs about inform ... WebApr 10, 2024 · Hikal Ltd., incorporated in the year 1988, is a Small Cap company (having a market cap of Rs 3,640.45 Crore) operating in Pharmaceuticals sector. Hikal Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Other Operating Revenue, Scrap and Export Incentives for the year ending 31-Mar-2024. Show More … impeachment release